References
1. Maziar Rahmani, Rani P. Cruz, David J. Granville, Bruce M. McManus – Allograft vasculopathy versus atherosclerosis, Circulation Research, 2006, 99: 801-815. DOI: 10.1161/01.RES.000024086.93555.f31. Maziar Rahmani, Rani P. Cruz, David J. Granville, Bruce M. McManus – Allograft vasculopathy versus atherosclerosis, Circulation Research, 2006, 99: 801-815. DOI: 10.1161/01.RES.000024086.93555.f3
2. Fransois Mach et al. – 2019 ESC/EAS Guidelines for the management of Dyslipidaemias: lipid modification to reduce cardiovascular risk, European Heart Journal, 2019; 00: 1-78. DOI: 10.1093/eurheartj/ehz455
3. Daniel Schmauss, Michael Weis – Cardiac allograft vasculopathy, Circulation, 2008; 117: 2131-2141. DOI: 10.1161/CIRCULATIONAHA.107.711911
4. Alykhan S. Nagji, Tjasa Hranjec, Brian R. Swenson, John A. Kern, James D. Bergin, David R. Jones, Irving L. Kron, Christine L. Lau, Gorav Ailawadi – Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation, Ann Thorac Surg, 2010; 90(1): 168-17
5. DOI: 10.1016/j.athoracsur.2010.03.0435. Brian Clarke, Kiran Khush – Cardiac allograft vasculopathy: an ongoing challenge in the care of heart transplant recipients, Cardiac Transplantation, 2012, 5: 79-98 www.intechopen.com
6. G. Vassalli, A. Gallino, M. Weis, W. von Scheidt, L. Kappenberger, L.K. von Segesser, J.-J. Goy, on behalf of Worling Group Microcirculation of the European Society of Cardiology, European Heart Journal, 2003, 24: 1180-1188. DOI: 10.1016/S0195-668X(03)00237-9
7. Ricardo Wang, Lidia Ana Zytynski Moura, Sergio Veiga Lopes, Francisco Dinoz Alfonso da Costa, Newton Fernando Stadler Souza Filho, Tiago Luiz Fernandes, Natalia Boing Salvatti, Jose Rocha Faria-Neto – Reduced progression of cardiac allograft vasculopathy with routine use of induction therapy with basiliximab, Arq Bras Cardiol, 2015; 7. DOI: 10.5935/abc.20150063
8. Maria Rosa Constanzo et al. – The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients, The Journal of Heart and Lung Transplantation, 2010; 29: 914-956. DOI: 10.1016/j.healun.2010.05.034
9. U. Julius, S. Tselmin, S. Fischer, J. Passauer, E. Tsourdi, S.R. Bornstein – Lipid apheresis after heart transplantation – the Dresden Experience, Transplantationsmedizin, 2010, 22: 355-362.
Notes to editor
Author information:
Dr. Maria Simonenko, MD
Almazov National Medical Research Centre, Saint-Petersburg, Russia
